TU Darmstadt / ULB / TUprints

NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells — A Potential Target for Adjuvant Radiotherapy

Müller-Längle, Adriana ; Lutz, Henrik ; Hehlgans, Stephanie ; Rödel, Franz ; Rau, Kerstin ; Laube, Bodo (2019)
NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells — A Potential Target for Adjuvant Radiotherapy.
In: Cancers, 2019, 11 (4)
Article, Secondary publication, Publisher's Version

[img]
Preview
Text
cancers-11-00503-v2.pdf
Copyright Information: CC BY 4.0 International - Creative Commons, Attribution.

Download (2MB) | Preview
Item Type: Article
Type of entry: Secondary publication
Title: NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells — A Potential Target for Adjuvant Radiotherapy
Language: English
Date: 2019
Place of Publication: Darmstadt
Year of primary publication: 2019
Publisher: MDPI
Journal or Publication Title: Cancers
Volume of the journal: 11
Issue Number: 4
Corresponding Links:
Origin: Secondary publication via sponsored Golden Open Access
Abstract:

Glioblastoma is one of the most aggressive malignant brain tumors, with a survival time less than 15 months and characterized by a high radioresistance and the property of infiltrating the brain. Recent data indicate that the malignancy of glioblastomas depends on glutamatergic signaling via ionotropic glutamate receptors. In this study we revealed functional expression of Ca2+-permeable NMDARs in three glioblastoma cell lines. Therefore, we investigated the impact of this receptor on cell survival, migration and DNA double-strand break (DSB) repair in the presence of both, glutamate and NMDAR antagonists, and after clinically relevant doses of ionizing radiation. Our results indicate that treatment with NMDAR antagonists slowed the growth and migration of glutamate-releasing LN229 cells, suggesting that activation of NMDARs facilitate tumor expansion. Furthermore, we found that DSB-repair upon radiation was more effective in the presence of glutamate. In contrast, antagonizing the NMDAR or the Ca2+-dependent transcription factor CREB impaired DSB-repair similarly and resulted in a radiosensitizing effect in LN229 and U-87MG cells, indicating a common link between NMDAR signaling and CREB activity in glioblastoma. Since the FDA-approved NMDAR antagonists memantine and ifenprodil showed differential radiosensitizing effects, these compounds may constitute novel optimizations for therapeutic interventions in glioblastoma

Status: Publisher's Version
URN: urn:nbn:de:tuda-tuprints-86542
Classification DDC: 500 Science and mathematics > 570 Life sciences, biology
Divisions: 10 Department of Biology > Neurophysiology and Neurosensory Systems
Date Deposited: 29 Apr 2019 10:13
Last Modified: 13 Dec 2022 10:20
URI: https://tuprints.ulb.tu-darmstadt.de/id/eprint/8654
PPN:
Export:
Actions (login required)
View Item View Item